Shortage of Ergometrine [notice to members]

5 Feb 2021

The TGA has been advised of an upcoming shortage of DBL Ergometrine Injection (AUST R 58866) from 12 February 2021 until 18 June 2021.

Ergometrine is used in the hospital setting during obstetric procedures following the delivery of the placenta to promote involution of the uterus in order to treat haemorrhage.

More details about the shortage and the alternative product that has been approved under section 19A of the Therapeutic Goods Act 1989 are available here.